231
Participants
Start Date
June 28, 2013
Primary Completion Date
January 26, 2016
Study Completion Date
November 10, 2023
Ceritinib
Ceritinib was the investigational treatment and was provided as 150 mg hard gelatin capsules for oral use. The dose was 750 mg once daily.
Pemetrexed
Pemetrexed was one of the chemotherapy treatments. Pemetrexed, a reconstituted solution, was intravenously administered over 10 minutes at 500 mg/m\^2 every 21 days.
Docetaxel
Docetaxel was one of the chemotherapy treatments. Docetaxel, a reconstituted solution, was intravenously administered over 1 hour, at 75 mg/m\^2 every 21 days.
Novartis Investigative Site, Brussels
Novartis Investigative Site, Brussels
Novartis Investigative Site, Edegem
Novartis Investigative Site, Leuven
Novartis Investigative Site, Lucerne
Novartis Investigative Site, Sankt Gallen
Novartis Investigative Site, Orbassano
Novartis Investigative Site, Marseille
Novartis Investigative Site, Caen
Novartis Investigative Site, A Coruña
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Milan
Novartis Investigative Site, Monza
Virginia Cancer Specialists, Fairfax
Novartis Investigative Site, Besançon
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Madrid
Novartis Investigative Site, Brest
Cancer Specialists of North Florida, Jacksonville
Memorial Cancer Institute, Hollywood
Novartis Investigative Site, Aviano
University Of Miami, Miami
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Pendik Istanbul
Novartis Investigative Site, Verona
Sarah Cannon Research Institute, Nashville
Novartis Investigative Site, Seville
Novartis Investigative Site, Seville
Novartis Investigative Site, Reggio Emilia
Novartis Investigative Site, Kfar Saba
Novartis Investigative Site, Essen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Cologne
Uni Of Iowa Hospitals And Clinics, Iowa City
Novartis Investigative Site, Ramat Gan
Novartis Investigative Site, Pisa
Loyola University Medical Center, Marywood
Novartis Investigative Site, Frankfurt
Novartis Investigative Site, Mulhouse
Novartis Investigative Site, Heidelberg
Novartis Investigative Site, Le Mans
Novartis Investigative Site, Tübingen
Highlands Oncology Group, Fayetteville
Novartis Investigative Site, Esslingen am Neckar
Oklahoma Cancer Specialists and Research Institute, Tulsa
Novartis Investigative Site, Paris
Texas Oncology Cancer Care and Research Center, Waco
Texas Oncology-Sugarland, Sugar Land
Novartis Investigative Site, Avellino
Novartis Investigative Site, Ulm
Novartis Investigative Site, Suresnes
Swedish Cancer Institute, Seattle
Novartis Investigative Site, Bad Berka
Novartis Investigative Site, Moscow
Novartis Investigative Site, Singapore
Novartis Investigative Site, Moscow Region Istra Village
Novartis Investigative Site, El Achrafiyé
Novartis Investigative Site, Singapore
Novartis Investigative Site, Saint Petersburg
Massachusetts General Hospital, Boston
Novartis Investigative Site, Toronto
Novartis Investigative Site, Strasbourg
Novartis Investigative Site, Hong Kong
Novartis Investigative Site, Pokfulam
Novartis Investigative Site, Limerick
Novartis Investigative Site, Dublin
Novartis Investigative Site, Perugia
Novartis Investigative Site, Roma
Novartis Investigative Site, Nagoya
Novartis Investigative Site, Kashiwa
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Akashi
Novartis Investigative Site, Okayama
Novartis Investigative Site, Hirakata
Novartis Investigative Site, Osaka
Novartis Investigative Site, Ōsaka-sayama
Novartis Investigative Site, Takatsuki
Novartis Investigative Site, Koto Ku
Novartis Investigative Site, Niigata
Novartis Investigative Site, Groningen
Novartis Investigative Site, Lisbon
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Ankara
Novartis Investigative Site, Cheltenham
Novartis Investigative Site, Aberdeen
Novartis Investigative Site, Leicester
Novartis Investigative Site, London
Novartis Investigative Site, Southampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY